Pharma · Private company
Astellas Pharma Europe B.V.
Track this companyFree. Adds Astellas Pharma Europe B.V. to your Dealase workspace and tells you when its record changes.
Clinical trials130 recruiting or active
Pipeline programs15From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline15
- Fidaxomicin oral suspensionPhase 3 · Clostridium Difficile-associated Diarrhea (CDAD)ClinicalTrials.gov · fetched Nov 12, 2026
- Fidaxomicin tabletsPhase 3 · Clostridium Difficile-associated Diarrhea (CDAD)ClinicalTrials.gov · fetched Nov 12, 2026
- MirabegronPhase 3 · Urinary Bladder OveractiveClinicalTrials.gov · fetched Nov 12, 2026
- Solifenacin succinatePhase 3 · Urinary Bladder OveractiveClinicalTrials.gov · fetched Nov 12, 2026
- Solifenacin succinatePhase 3 · Neurogenic Detrusor OveractivityClinicalTrials.gov · fetched Nov 12, 2026
- Solifenacin succinate suspensionPhase 3 · Urinary Bladder, OveractiveClinicalTrials.gov · fetched Nov 12, 2026
- UrotherapyPhase 3 · Urinary Bladder, OveractiveClinicalTrials.gov · fetched Nov 12, 2026
- Vancomycin capsulesPhase 3 · Clostridium Difficile-associated Diarrhea (CDAD)ClinicalTrials.gov · fetched Nov 12, 2026
- Vancomycin oral liquidPhase 3 · Clostridium Difficile-associated Diarrhea (CDAD)ClinicalTrials.gov · fetched Nov 12, 2026
- ASP8232Phase 2 · Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- ranibizumabPhase 2 · Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- Sham intravitreal (IVT) injectionPhase 2 · Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- ASP1128Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- Other parenteral antifungal drugsSystemic Fungal InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- Parenteral micafungin applicationSystemic Fungal InfectionsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials13
- A Study of MA-0217 (ASP1128) in Healthy Adult Subjects and Healthy Elderly SubjectsPHASE1 · COMPLETED · started Nov 20, 2017ClinicalTrials.gov NCT04742517 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD on Stable DialysisPHASE3 · COMPLETED · started Jan 15, 2015ClinicalTrials.gov NCT02273726 · fetched Nov 12, 2026
- A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)PHASE2 · COMPLETED · started Jan 12, 2015ClinicalTrials.gov NCT02302079 · fetched Nov 12, 2026
- A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)PHASE3 · COMPLETED · started Jan 9, 2015ClinicalTrials.gov NCT02218372 · fetched Nov 12, 2026
- A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive BladderPHASE3 · COMPLETED · started Mar 17, 2014ClinicalTrials.gov NCT02045862 · fetched Nov 12, 2026
- Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis ParticipantsPHASE3 · COMPLETED · started Feb 11, 2014ClinicalTrials.gov NCT02052310 · fetched Nov 12, 2026
- This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive BladderPHASE3 · COMPLETED · started Nov 5, 2013ClinicalTrials.gov NCT01972841 · fetched Nov 12, 2026
- A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)PHASE3 · COMPLETED · started Sep 25, 2013ClinicalTrials.gov NCT01981954 · fetched Nov 12, 2026
- A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving DialysisPHASE3 · COMPLETED · started Nov 5, 2012ClinicalTrials.gov NCT01750190 · fetched Nov 12, 2026
- A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076PHASE3 · COMPLETED · started Oct 4, 2012ClinicalTrials.gov NCT01655069 · fetched Nov 12, 2026
- Short and Long-term Safety of Micafungin and Other Parenteral Antifungal AgentsCOMPLETED · started Oct 1, 2012ClinicalTrials.gov NCT01686607 · fetched Nov 12, 2026
- A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor OveractivityPHASE3 · COMPLETED · started Aug 14, 2012ClinicalTrials.gov NCT01565694 · fetched Nov 12, 2026
- A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active DrugPHASE3 · COMPLETED · started Jun 7, 2012ClinicalTrials.gov NCT01565707 · fetched Nov 12, 2026